TEMPLE CITY, Calif., Nov. 15, 2016 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (Nasdaq:FLGT) today announced that Ming Hsieh, Chairman and Chief Executive Officer, and Paul Kim, Chief Financial Officer, are scheduled to participate in a fireside chat at the 28 th Annual Piper Jaffray Healthcare Conference at the Lotte New York Palace hotel on Tuesday, November 29, 2016 at 10:00 AM Eastern Time. The live audio webcast can be accessed in the Investor Relations section of the company's website, www.fulgentgenetics.com. An audio replay of the webcast will remain available on the company's website through December 29, 2016. About Fulgent Genetics, Inc. Fulgent Genetics is a rapidly growing technology company with an initial focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. The company has developed a proprietary technology platform that integrates sophisticated data comparison and suppression algorithms, adaptive leaning software, advanced genetic diagnostic tools, and integrated laboratory processes. This platform allows the company to offer a broad and flexible test menu while maintaining accessible pricing, high accuracy, and competitive turnaround times. The company believes its current test menus, which includes more than 18,000 single-gene tests and more than 250 pre-established, multi-gene, disease-specific panels, offers more genes for testing than its competitors in today's market, which enables it to provide expansive options for test customization and clinically actionable results.
Investor Contact:The Blueshirt GroupBob Jones, 212- 871-5570, firstname.lastname@example.org